High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists

Author： Wang P.-R.   Guo Q.   Ippolito M.   Wu M.   Milot D.   Ventre J.   Doebber T.   Wright S.D.   Chao Y.-S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.427, Iss.3, 2001-09, pp. : 285-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Updates on Peroxisome Proliferator-Activated Receptor δ Agonists for the Treatment of Metabolic Syndrome

By  

Medicinal Chemistry, Vol. 12, Iss. 1, 2016-02 ,pp. : 3-21

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Evaluation of Peroxisome Proliferator-Activated Receptor /&bgr;Dual Agonists for the Treatment of Type 2 Diabetes

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 1, 2007-01 ,pp. : 27-32

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir   Bansal Dipika   Shafiq Nusrat   Pandhi Promila   Kumar Bhushan  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1129-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer

By Fenner Martin H   Elstner Elena  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 557-568

Informa Healthcare

Access to resources Recommend Favorite